Fairvalue-Calculator Fairvalue-Calculator
EN DE

Alligator Bioscience AB (ATORX) Fair Value & Analysis

Healthcare · SE · Market cap 127M SEK

Pricekr 0.1682
Fair Valuekr 0.1400
Upside-16.8%
Quality95/100
Evidence: Low Range kr 0.0800 – kr 0.1700

Fair value as of: Jun 26, 2026

Analysis

Alligator Bioscience AB (ATORX) currently trades at kr 0.1682, while our model-based Fair Value estimate is kr 0.1400 — implying the stock looks roughly 16.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium. The company develops Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 3 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage for the treatment of solid metastatic tumors. It also offers ALG.APV-527, a bispecific antibody that targets the 4-1BB and 5T4 molecules, which is in phase 2 clinical trial for the treatment of solid metastatic tumors; and ATOR-1017, a monoclonal antibody that stimulates the 4-1BB receptor on T cells and NK cells in the tumor, which is in phase 1 for the treatment of solid metastatic cancers; and HLX22, an antibody that treats metastatic, gastric, and breast cancers, which is in phase 3 clinical trial. In additio…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Alligator Bioscience AB (ATORX) undervalued?
As of Jun 26, 2026, our model estimates a fair value of kr 0.1400 versus a price of kr 0.1682 — about −17% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ATORX?
Our 21-model fair value for Alligator Bioscience AB is kr 0.1400 (as of Jun 26, 2026), built from audited fundamentals. The current price is kr 0.1682.
What is the quality score of ATORX?
Alligator Bioscience AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.